Zosano Pharma Corporation
https://www.zosanopharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zosano Pharma Corporation
Keeping Track: Incomplete Responses For Unusual Times; Qtrypta Is Latest CRL
Highlights from complete response letter news from the Pink Sheet’s US FDA Performance Tracker.
Asia Deal Watch: Takeda Will Employ Engitix’s ECM Tech In Liver Fibrosis Indications
Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.
Pipeline Watch: Phase III Progress With Tecentriq, Rolontis And ADV7103
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Finance Watch: Hua Medicine Raises $117.4m While Evaluating A Hong Kong IPO
Hua, already considering an IPO in Hong Kong for up to $400m, closed concurrent VC rounds that will fund its late-stage diabetes program in China, but it may still need to go public to enter other markets. Also, Heron raised cash for its next commercial product, among other public company financings.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
- Other Names / Subsidiaries
-
- The Macroflux Company